Biotech News ButlerBiotech News ButlerBETA
TrendingFeedbackLog In

Trending News in Biotech

Top stories being covered by multiple trusted sources right now

Aldeyra reproxalap hits third FDA CRL
Aldeyra dry eye drug gets third rejection from FDA, triggering stock slide— Endpoints NewsAldeyra collects third CRL for reproxalap in dry eye disease— BioWorld (Clarivate)Third FDA Rejection for Aldeyra’s Dry Eye Disease Drug Sends Shares Plummeting— BioSpaceFREE
Federal judge blocks RFK vaccine overhaul
Federal court blocks RFK Jr.’s moves to upend US vaccine policy— BioPharma DiveFREEKennedy’s Vaccine Policy Overhaul Stymied by Federal Judge— BioSpaceFREE/C O R R E C T I O N -- Federal Judge Blocks Immunization Schedule Changes, Stays ACIP Member Appointments/— PR Newswire - HealthFREE
Rhythm Imcivree flops in Phase 3
Rhythm’s Imcivree fails Phase 3 rare form obesity trial— Endpoints NewsRhythm’s Imcivree Fails Late-Stage Weight Loss Trial in Rare Obesities— BioSpaceFREERhythm Pharmaceuticals Announces Topline Results from Phase 3 EMANATE Trial— Globle News Wire - Clinical Study
BioMarin pauses Voxzogo trials on safety
BioMarin halts Voxzogo trials due to safety signal— pharmaphorumFREEBioMarin halts Phase 2 Voxzogo dosing in certain patients over safety concern— Endpoints NewsBioMarin Pauses Dosing, Enrollment in 2 Voxzogo Studies After Safety Signal— BioSpaceFREE
CytomX masked ADC posts positive CRC data
CytomX surges on positive data for ‘masked’ ADC in colorectal cancer— BioPharma DiveFREECytomx soars as early colorectal cancer data beat expectations— BioWorld (Clarivate)CytomX reports ADC data in late-line colorectal cancer; FDA OKs Cosentyx label expansion— Endpoints News
Semaglutide faces India promo crackdown
From Potential ‘Bloodbath’ To Promo Warnings: Semaglutide’s India Reckoning— Citeline - ScripIndia Semaglutide ‘Bloodbath,’ Rx Memory And Regulatory Warning On Promos— Citeline - Pink Sheet
AACR 2026: oncology pipeline presentation roundup
Revolution Medicines to Showcase Progress Across RAS(ON) Targeted Oncology Pipeline with Multiple Presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting— Globle News Wire - Clinical StudyORIC® Pharmaceuticals Announces Preclinical Rinzimetostat (ORIC-944) Presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting— Globle News Wire - HealthAdagene’s Muzastotug (ADG126) to be Highlighted in Two Presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting in San Diego, CA— Globle News Wire - Clinical Study
Biotech weekly roundup: deals, clinic, regs
Appointments and advancements for March 17, 2026— BioWorld (Clarivate)Financings for March 17, 2026— BioWorld (Clarivate)In the clinic for March 17, 2026— BioWorld (Clarivate)
Roche wins CE mark for ApoE4 test
Roche secures CE mark for blood test to identify ApoE4 carriers— BioWorld (Clarivate)Roche receives CE mark for first IVD immunoassay blood test to identify carriers of ApoE4, a genetic variant present in up to 60% of patients diagnosed with Alzheimer's disease— PR Newswire - HealthFREERoche receives CE mark for first IVD immunoassay blood test to identify carriers of ApoE4, a genetic variant present in up to 60% of patients diagnosed with Alzheimer's disease— PR Newswire - HealthFREE
Structure oral GLP-1 shows 44-week obesity data
44-week data bolster best-in-class case for Structure’s obesity pill— BioCenturyStructure’s GLP-1 pill shows ‘best-in-class’ potential in obesity trial— BioPharma DiveFREEStructure Climbs on ‘Highly Competitive’ Profile for Weight Loss Pill— BioSpaceFREE

Updated every few hours. Subscribe to get personalized digests delivered to your inbox.